Journal
FEMS YEAST RESEARCH
Volume 6, Issue 8, Pages 1140-1148Publisher
OXFORD UNIV PRESS
DOI: 10.1111/j.1567-1364.2006.00097.x
Keywords
Candida albicans; candidiasis; apoptosis; lovastatin; pseudomycelium; chemotherapy
Ask authors/readers for more resources
Lovastatin inhibited the growth of Candida albicans in a fungistatic way. Although it triggers apoptosis in a great variety of eukaryotic cells, including many tumour cell lines, lovastatin failed to provoke apoptotic events in this human pathogen. The fungistatic behaviour of this statin might arise from its negative influence on membrane fluidity. Because yeast -> pseudomycelium and hyphae morphogenetic transitions took place under exposure to lovastatin morphogenetic switch and apoptotic cell death must be regulated independently in C. albicans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available